Nutren Aqua Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -13.70%
- Profit Growth 226.67%
- Ebitda 95.85%
- Net Worth 12.70%
- Total Assets -25.13%
About Nutren Aqua Biotech India
Nutren Aqua Biotech India Private Limited (NABIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2015 (Nine years and four months 0 days old ). Its registered office is in Prakasam, Andhra Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Dhulipalla and Suneetha Manne serve as directors at the Company.
Company Details
- Location
Prakasam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U01403TG2015PTC100995
- Company No.
100995
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Nutren Aqua Biotech India Private Limited offer?
Nutren Aqua Biotech India Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Nutren Aqua Biotech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Dhulipalla  | Director | 01-Oct-2015 | Current |
| Suneetha Manne | Director | 01-Oct-2015 | Current |
Financial Performance of Nutren Aqua Biotech India.
Nutren Aqua Biotech India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.7% decrease. The company also saw a substantial improvement in profitability, with a 226.67% increase in profit. The company's net worth Soared by an impressive increase of 12.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutren Aqua Biotech India?
In 2019, Nutren Aqua Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zectovet Chemical Private LimitedAshok Dhulipalla and Suneetha Manne are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutren Aqua Biotech India?
Unlock and access historical data on people associated with Nutren Aqua Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutren Aqua Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutren Aqua Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.